Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)
Germany
· Delayed Price · Currency is EUR 30.60
+0.40 (1.32%)
Last updated: Aug 14, 2025
Kobayashi Pharmaceutical Revenue
Kobayashi Pharmaceutical had revenue of 36.41B JPY in the quarter ending June 30, 2025, a decrease of -0.65%. This brings the company's revenue in the last twelve months to 161.48B, down -6.64% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.
Revenue (ttm)
161.48B JPY
Revenue Growth
-6.64%
P/S Ratio
2.45
Revenue / Employee
44.67M JPY
Employees
3,615
Market Cap
2.33B EUR
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Energy AG | 38.39B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Rheinmetall AG | 10.67B |
| Deutsche Bank Aktiengesellschaft | 30.07B |